NOTCH1 and FBXW7 mutations have a favorable impact on early response to treatment, but not on outcome, in children with T-cell acute lymphoblastic leukemia (T-ALL) treated on EORTC trials 58881 and 58951

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Leukemia

• Publication date

  2010-09-23

• Fields of study

  Medicine

• Identifiers
  DOI 10.1038/leu.2010.205PMID 20861920
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• NOTCH1 and/or FBXW7 mutations predict for initial good prednisone response but not for improved outcome in pediatric T-cell acute lymphoblastic leukemia patients treated on DCOG or COALL protocols

  2010cited by this paper
• The favorable effect of activating NOTCH1 receptor mutations on long-term outcome in T-ALL patients treated on the ALL–BFM 2000 protocol can be separated from FBXW7 loss of function

  2010cited by this paper
• Wilms tumor 1 (WT1) gene mutations in pediatric T-cell malignancies

  2009cited by this paper
• Treating childhood acute lymphoblastic leukemia without cranial irradiation.

  2009cited by this paper
• CCR7 signalling as an essential regulator of CNS infiltration in T-cell leukaemia

  2009cited by this paper
• NOTCH1/FBXW7 mutation identifies a large subgroup with favorable outcome in adult T-cell acute lymphoblastic leukemia (T-ALL): a Group for Research on Adult Acute Lymphoblastic Leukemia (GRAALL) study.

  2009cited by this paper
• High-resolution genomic profiling of childhood T-ALL reveals frequent copy-number alterations affecting the TGF-beta and PI3K-AKT pathways and deletions at 6q15-16.1 as a genomic marker for unfavorable early treatment response.

  2009cited by this paper
• The Favorable Effect of Activating NOTCH1 Receptor Mutations On Long Term Outcome in T-ALL Is Treatment Related and Can Be Separated From NOTCH Pathway Activation by FBXW7 Loss of Function.

  2009cited by this paper
• Prognostic implications of NOTCH1 and FBXW7 mutations in adults with T-cell acute lymphoblastic leukemia treated on the MRC UKALLXII/ECOG E2993 protocol.

  2009cited by this paper
• Gamma-secretase inhibitors reverse glucocorticoid resistance in T-ALL

  2008cited by this paper
• Molecular pathogenesis of T-cell leukaemia and lymphoma

  2008cited by this paper
• It's T-ALL about Notch

  2008cited by this paper
• Leukemia-associated NOTCH1 alleles are weak tumor initiators but accelerate K-ras-initiated leukemia.

  2008cited by this paper
• Prognostic significance of molecular-cytogenetic abnormalities in pediatric T-ALL is not explained by immunophenotypic differences

  2008cited by this paper
• The SCFFBW7 ubiquitin ligase complex as a tumor suppressor in T cell leukemia

  2007cited by this paper
• The tumor suppressor gene hCDC4 is frequently mutated in human T-cell acute lymphoblastic leukemia with functional consequences for Notch signaling.

  2007cited by this paper
• FBW7 mutations in leukemic cells mediate NOTCH pathway activation and resistance to γ-secretase inhibitors

  2007cited by this paper
• Chromosomally unstable mouse tumours have genomic alterations similar to diverse human cancers

  2007cited by this paper
• Cytogenetics and molecular genetics of T-cell acute lymphoblastic leukemia: from thymocyte to lymphoblast

  2006cited by this paper
• NOTCH1 Mutations in T-Cell Acute Lymphoblastic Leukemia: Prognostic Significance and Implication in Multifactorial Leukemogenesis

  2006cited by this paper
• Activating NOTCH1 mutations predict favorable early treatment response and long-term outcome in childhood precursor T-cell lymphoblastic leukemia.

  2006cited by this paper
• Notch 1 activation in the molecular pathogenesis of T-cell acute lymphoblastic leukaemia

  2006cited by this paper
• Benefit of dexamethasone compared with prednisolone for childhood acute lymphoblastic leukaemia: results of the UK Medical Research Council ALL97 randomized trial

  2005cited by this paper
• Activating Notch1 mutations in mouse models of T-ALL.

  2005cited by this paper
• HOXA genes are included in genetic and biologic networks defining human acute T-cell leukemia (T-ALL).

  2005cited by this paper
• Clinical significance of HOX11L2 expression linked to t(5;14)(q35;q32), of HOX11 expression, and of SIL-TAL fusion in childhood T-cell malignancies: results of EORTC studies 58881 and 58951.

  2004cited by this paper
• Satelite Symposium V, Meet-the-Professor Sessions I and II, Main Sessions I-IX

  2004cited by this paper
• Activating Mutations of NOTCH1 in Human T Cell Acute Lymphoblastic Leukemia

  2004cited by this paper
• Acute lymphoblastic leukemia.

  2004cited by this paper
• The Anti-apoptotic Effect of Notch-1 Requires p56lck-dependent, Akt/PKB-mediated Signaling in T Cells*

  2004cited by this paper
• Dexamethasone versus prednisone and daily oral versus weekly intravenous mercaptopurine for patients with standard-risk acute lymphoblastic leukemia: a report from the Children's Cancer Group.

  2003cited by this paper
• Gene expression profiling in T-cell acute lymphoblastic leukemia.

  2003cited by this paper
• CALM-AF10 is a common fusion transcript in T-ALL and is specific to the TCRgammadelta lineage.

  2003cited by this paper
• Standardization and quality control studies of ‘real-time’ quantitative reverse transcriptase polymerase chain reaction of fusion gene transcripts for residual disease detection in leukemia – A Europe Against Cancer Program

  2003cited by this paper
• CALM-AF10 is a common fusion transcript in T-ALL and is specific to the TCRγδ lineage

  2003cited by this paper
• Gene expression signatures define novel oncogenic pathways in T cell acute lymphoblastic leukemia.

  2002cited by this paper
• A competitive PCR-based method using TCRD, TCRG and IGH rearrangements for rapid detection of patients with high levels of minimal residual disease in acute lymphoblastic leukemia

  2002cited by this paper
• Notch signaling in leukemia

  2001cited by this paper
• Separation of Notch1 Promoted Lineage Commitment and Expansion/Transformation in Developing T Cells

  2001cited by this paper
• Functional Interaction between SEL-10, an F-box Protein, and the Nuclear Form of Activated Notch1 Receptor*

  2001cited by this paper
• Long-term results of three randomized trials (58831, 58832, 58881) in childhood acute lymphoblastic leukemia: a CLCG-EORTC report

  2000cited by this paper
• Essential Roles for Ankyrin Repeat and Transactivation Domains in Induction of T-Cell Leukemia by Notch1

  2000cited by this paper
• Long-term results of three randomized trials (58831, 58832, 58881) in childhood acute lymphoblastic leukemia: a CLCG-EORTC report. Children Leukemia Cooperative Group.

  2000cited by this paper
• Clinical significance of minimal residual disease in childhood acute lymphoblastic leukemia. European Organization for Research and Treatment of Cancer--Childhood Leukemia Cooperative Group.

  1998cited by this paper
• Clinical Significance of Minimal Residual Disease in Childhood Acute Lymphoblastic Leukemia

  1998cited by this paper
• Correlating notch signaling with thymocyte maturation.

  1998cited by this paper
• Exclusive development of T cell neoplasms in mice transplanted with bone marrow expressing activated Notch alleles

  1996cited by this paper
• Prospective monitoring and quantitation of residual blasts in childhood acute lymphoblastic leukemia by polymerase chain reaction study of delta and gamma T-cell receptor genes.

  1994cited by this paper

• NOTCH1 mutation status as a prognostic biomarker in T-cell acute lymphoblastic leukemia: a systematic review and meta-analysis

  2025influential citation
• Comprehensive Analysis of NOTCH1 Mutations in Indian Pediatric ALL Patients: Clinical and Molecular Insights

  2025cites this paper
• USP7 mutations are associated with adverse outcomes in pediatric T cell acute lymphoblastic leukemia and lymphoma

  2025cites this paper
• Pediatric Acute Lymphoblastic Leukemia, Version 2.2025, NCCN Clinical Practice Guidelines In Oncology.

  2025cites this paper
• Significance of immunophenotypic, cytogenetic, and molecular markers in adult patients with T-cell lymphoblastic leukemia

  2024cites this paper
• T-cell lymphoblastic lymphoma compared with T-cell acute lymphoblastic leukemia: similar subtypes and different fusions

  2024cites this paper
• 成人T淋巴母细胞淋巴瘤诊断与治疗中国专家共识（2023年版）

  2023cites this paper
• NGS-based stratification refines the risk stratification in T-ALL and identifies a Very High-Risk subgroup of patients.

  2023cites this paper
• Emerging Epigenetic and Posttranslational Mechanisms Controlling Resistance to Glucocorticoids in Acute Lymphoblastic Leukemia

  2023cites this paper
• Prognostic significance of NOTCH1/FBXW7 mutations in pediatric T cell acute lymphoblastic leukemia: a study of minimal residual disease risk-directed CCLG-ALL 2008 treatment protocol

  2022cites this paper
• Molecular genetic abnormalities in patients with T-cell acute lymphoblastic leukemia: a literature review

  2022cites this paper
• Integrated clinical genotype‐phenotype characteristics of early T‐cell precursor acute lymphoblastic leukemia

  2022cites this paper
• The role of SF3B1 and NOTCH1 in the pathogenesis of leukemia

  2022cites this paper
• Oncogenetic landscape of T-cell lymphoblastic lymphomas compared to T-cell acute lymphoblastic leukemia

  2022cites this paper
• Hyperprogression, a challenge of PD-1/PD-L1 inhibitors treatments: potential mechanisms and coping strategies.

  2022cites this paper
• Overcoming Steroid Resistance in Pediatric Acute Lymphoblastic Leukemia—The State-of-the-Art Knowledge and Future Prospects

  2022cites this paper
• Treatment of Elderly Patients with Acute Lymphoblastic Leukemia

  2022cites this paper
• DNA Methylation in T-Cell Acute Lymphoblastic Leukemia: In Search for Clinical and Biological Meaning

  2021cites this paper
• Oxidative Stress and Notch Signaling

  2021cites this paper
• T-Cell Acute Lymphoblastic Leukemia: Biomarkers and Their Clinical Usefulness

  2021cites this paper
• Prognostic value of Oncogenetic mutations in pediatric T Acute Lymphoblastic Leukemia: a comparison of UKALL2003 and FRALLE2000T protocols

  2021cites this paper
• NOTCH1在急性T淋巴细胞白血病中的作用及研究进展

  2021cites this paper
• The Role of Notch, Hedgehog, and Wnt Signaling Pathways in the Resistance of Tumors to Anticancer Therapies

  2021cites this paper
• The FBXW7‐NOTCH interactome: A ubiquitin proteasomal system‐induced crosstalk modulating oncogenic transformation in human tissues

  2021cites this paper
• Measurable Residual Disease Assessed by Flow-Cytometry Is a Stable Prognostic Factor for Pediatric T-Cell Acute Lymphoblastic Leukemia in Consecutive SEHOP Protocols Whereas the Impact of Oncogenetics Depends on Treatment

  2021cites this paper
• The Physiopathology of T- Cell Acute Lymphoblastic Leukemia: Focus on Molecular Aspects

  2020cites this paper
• Integrative genomic analysis of pediatric T- cell lymphoblastic lymphoma reveals candidates of clinical significance.

  2020cites this paper
• A Molecular Test for Quantifying Functional Notch Signaling Pathway Activity in Human Cancer

  2020cites this paper
• Identification of prognostic factors in childhood T‐cell acute lymphoblastic leukemia: Results from DFCI ALL Consortium Protocols 05‐001 and 11‐001

  2020cites this paper
• Pediatric acute lymphoblastic leukemia

  2020influential citation
• T-cell lymphoblastic lymphoma and leukemia: different diseases from a common premalignant progenitor?

  2020cites this paper
• Development of a Notch pathway assay and quantification of functional Notch pathway activity in T-cell acute lymphoblastic leukemia

  2020cites this paper
• Progress in research on childhood T-cell acute lymphocytic leukemia, Notch1 signaling pathway, and its inhibitors: A review

  2020cites this paper
• PEST domain NOTCH mutations confer a poor relapse free survival in pediatric T-ALL: Data from a tertiary care centre in India.

  2020cites this paper
• Pediatric Acute Lymphoblastic Leukemia, Version 2.2020, NCCN Clinical Practice Guidelines in Oncology.

  2020cites this paper
• Results of successive EORTC‐CLG 58 881 and 58 951 trials in paediatric T‐cell acute lymphoblastic leukaemia (ALL)

  2019cites this paper
• NOTCH1 pathway activating mutations and clonal evolution in pediatric T‐cell acute lymphoblastic leukemia

  2019cites this paper
• The depletion of PHF6 decreases the drug sensitivity of T-cell acute lymphoblastic leukemia to prednisolone.

  2019cites this paper
• CRLF2 expression associates with ICN1 stabilization in T‐cell acute lymphoblastic leukemia

  2019cites this paper
• The Profile of Immunophenotype and Genotype Aberrations in Subsets of Pediatric T-Cell Acute Lymphoblastic Leukemia

  2019cites this paper
• T‐cell acute lymphoblastic leukemia: Current approach and future directions

  2019cites this paper
• Mechanisms of Glucocorticoid Response and Resistance in Lymphoid Malignancies

  2019cites this paper
• Prognostic relevance of genetic variations in T-cell acute lymphoblastic leukemia/lymphoblastic lymphoma

  2019cites this paper
• RAS and TP53 can predict survival in adults with T‐cell lymphoblastic leukemia treated with hyper‐CVAD

  2019cites this paper
• Pediatric T-Cell Acute Lymphobastic Leukemia

  2019cites this paper
• Interrogating the Mechanistic Basis for Cytokine-Mediated Glucocorticoid Resistance in Lymphoid-Driven Diseases

  2019cites this paper
• NCCN CLINICAL PRACTICE GUIDELINES IN ONCOLOGY Pediatric Acute Lymphoblastic Leukemia, Version 2.2020

  2019cites this paper
• Clinical significance of cytogenetic changes in childhood T-cell acute lymphoblastic leukemia: results of the multicenter group Moscow–Berlin (MB)

  2018cites this paper
• Diagnosis and Treatment of Childhood Acute Lymphoblastic Leukemia

  2018cites this paper
• The potential of precision medicine for childhood acute lymphoblastic leukemia: opportunities and challenges

  2018cites this paper
• Recent Advances in the Biology and Treatment of T Cell Acute Lymphoblastic Leukemia

  2018cites this paper
• Oncogenetic mutations combined with MRD improve outcome prediction in pediatric T-cell acute lymphoblastic leukemia.

  2018cites this paper
• Notch in Leukemia.

  2018cites this paper
• Clinical and biological relevance of genetic alterations in pediatric T‐cell acute lymphoblastic leukemia in Taiwan

  2018cites this paper
• Clinical impact of miR-223 expression in pediatric T-Cell lymphoblastic lymphoma

  2017cites this paper
• Meta-analysis of the clinical characteristics and prognostic relevance of NOTCH1 and FBXW7 mutation in T-cell acute lymphoblastic leukemia

  2017cites this paper
• Management of adults with T-cell lymphoblastic leukemia.

  2017cites this paper
• NOTCH1 mutation, TP53 alteration and myeloid antigen expression predict outcome heterogeneity in children with first relapse of T-cell acute lymphoblastic leukemia

  2017cites this paper
• Identification of a genetically defined ultra-high-risk group in relapsed pediatric T-lymphoblastic leukemia

  2017cites this paper
• Initial Diagnostic Workup of Acute Leukemia: Guideline From the College of American Pathologists and the American Society of Hematology.

  2017cites this paper
• Targeting Notch as a Therapeutic Approach for Human Malignancies.

  2016cites this paper
• Current status and future directions of T‐lymphoblastic lymphoma in children and adolescents

  2016cites this paper
• Characterization of select downstream effectors of oncogenic NOTCH1 in T-cell acute lymphoblastic leukemia

  2016cites this paper
• Oncogenic Notch signaling in T-cell and B-cell lymphoproliferative disorders

  2016cites this paper
• Cytogenetics in the management of children and adult acute lymphoblastic leukemia (ALL): an update by the Groupe francophone de cytogénétique hématologique (GFCH).

  2016cites this paper
• ZEBRAFISH XENOTRANSPLANTATION AS A PRECLINICAL THERAPEUTIC PLATFORM FOR T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA

  2016cites this paper
• Targeting Notch degradation system provides promise for breast cancer therapeutics.

  2016cites this paper
• Notch and Wnt signaling pathway in cancer: Crucial role and potential therapeutic targets (Review).

  2016cites this paper
• Genomic characterization of pediatric T-cell acute lymphoblastic leukemia reveals novel recurrent driver mutations

  2016cites this paper
• How I treat T-cell acute lymphoblastic leukemia in adults.

  2015cites this paper
• [Acute lymphoblastic leukemia of T progenitors: from biology to clinics].

  2015cites this paper
• NOTCH1 and FBXW7 Mutations Favor Better Outcome in Pediatric South Indian T-Cell Acute Lymphoblastic Leukemia

  2015cites this paper
• Leucemia aguda linfoblástica de precursores T: de la biología a la clínica

  2015cites this paper
• Implications of basic research in clinical practice: toward a personalizedmedicine in T-cell Acute Lymphoblastic Leukemia (T-ALL)

  2015cites this paper
• Impact of PTEN abnormalities on outcome in pediatric patients with T-cell acute lymphoblastic leukemia treated on the MRC UKALL2003 trial

  2015cites this paper
• Different outcome of T cell acute lymphoblastic leukemia with translocation t(11;14) treated in two consecutive children leukemia group EORTC trials

  2015cites this paper
• Update on biology and treatment of T-cell acute lymphoblastic leukaemia

  2015cites this paper
• A NOTCH1-driven MYC enhancer promotes T cell development, transformation and acute lymphoblastic leukemia

  2014cites this paper
• NOTCH1 mutations are associated with favourable long‐term prognosis in paediatric T‐cell acute lymphoblastic leukaemia: a retrospective study of patients treated on BCH‐2003 and CCLG‐2008 protocol in China

  2014cites this paper
• From fly wings to targeted cancer therapies: a centennial for notch signaling.

  2014cites this paper
• Alteration of NOTCH1 in T-cell Acute Lymphoblastic Leukemia and Development of Target Therapeutic Agent

  2014cites this paper
• The Challenge of Targeting Notch in Hematologic Malignancies

  2014cites this paper
• Prognostic implications of mutations in NOTCH1 and FBXW7 in childhood T‐all treated according to the NOPHO ALL‐1992 and ALL‐2000 protocols

  2014cites this paper
• Identification of novel NOTCH1 mutations: Increasing our knowledge of the NOTCH signaling pathway

  2014cites this paper
• Section II: hematolymphoid malignancies.

  2014cites this paper
• N-Me, a long range oncogenic enhancer in T-cell acute lymphoblastic leukemia

  2014cites this paper
• Interleukin-18 produced by bone marrow-derived stromal cells supports T-cell acute leukaemia progression

  2014cites this paper
• Prognostic markers in pediatric leukemia and mechanisms of KRAS induced leukemogenesis

  2013influential citation
• Breakpoint-specific multiplex polymerase chain reaction allows the detection of IKZF1 intragenic deletions and minimal residual disease monitoring in B-cell precursor acute lymphoblastic leukemia

  2013cites this paper
• Lymphoblastic Lymphoma in Childhood and Adolescence

  2013cites this paper
• FBXW7 regulates glucocorticoid response in T-cell acute lymphoblastic leukaemia by targeting the glucocorticoid receptor for degradation

  2013cites this paper
• The molecular profile of adult T‐cell acute lymphoblastic leukemia: Mutations in RUNX1 and DNMT3A are associated with poor prognosis in T‐ALL

  2013cites this paper
• Incidence and prognostic relevance of genetic variations in T-cell lymphoblastic lymphoma in childhood and adolescence.

  2013cites this paper
• LYMPHOID NEOPLASIA Incidence and prognostic relevance of genetic variations in T-cell lymphoblastic lymphoma in childhood and adolescence

  2013cites this paper
• NOTCH1 activation clinically antagonizes the unfavorable effect of PTEN inactivation in BFM-treated children with precursor T-cell acute lymphoblastic leukemia

  2013cites this paper
• Gene mutation profiles and prognostic implications in Korean patients with T-lymphoblastic leukemia

  2013cites this paper
• MicroRNAs and Glucocorticoid-Induced Apoptosis in Lymphoid Malignancies

  2013cites this paper
• The NOTCH signaling pathway: role in the pathogenesis of T-cell acute lymphoblastic leukemia and implication for therapy

  2013cites this paper
• Lessons from next-generation sequencing analysis in hematological malignancies

  2013cites this paper
• Molecular Pathogenesis of T Lymphoblastic Lymphomas in an Atm-deficient Mouse Model

  2013cites this paper